On May 27, 2011 the Council of the European Union (Council) adopted a directive aimed at preventing falsified medicines from entering into the legal supply chain. Notably, the directive imposes obligations on all actors in the distribution chain, including importers, traders, manufacturers, distributors, and any operator who repackages a product.